Tapewire

Nasdaq · USD

INSM

INSMED Inc

Export transactions ↓
Tapewire entity
3174
SEC CIK
0001104506
Parsed reports
490

Last 12 months

Inside the activity.

0 purchase rows · 169 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 2025018
Jan 2026044
Feb 2026022
Mar 202608
Apr 2026010
May 2026019
Jun 2026013
Jul 202607
Aug 202604
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 10, 2023 Filed Jan 12, 2023 21:14 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 779 $17.96 $13,990.84
Disclosure

SEC source: 0001628280-23-000963 · wf-form4_167355804099417.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,272

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 779 shares sold at prices ranging from $17.93 to $17.98 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 10, 2023 Filed Jan 12, 2023 21:11 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 2,435 $17.95 $43,708.25
Disclosure

SEC source: 0001628280-23-000961 · wf-form4_167355789878115.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,159

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,435 shares sold at prices ranging from $17.93 to $17.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 10, 2023 Filed Jan 12, 2023 21:13 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
SaleCommon Stock 1,836 $17.93 $32,919.48
Disclosure

SEC source: 0001628280-23-000962 · wf-form4_167355796596777.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,332

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 1,836 shares sold at prices ranging from $17.92 to $17.96 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 10, 2023 Filed Jan 12, 2023 21:10 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 6,994 $18.00 $125,892.00
Disclosure

SEC source: 0001628280-23-000960 · wf-form4_167355782601813.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,067

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is a weighted average sales price representing 6,994 shares sold at prices ranging from $17.97 to $18.02 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 10, 2023 Filed Jan 12, 2023 21:09 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 3,439 $18.06 $62,108.34
Disclosure

SEC source: 0001628280-23-000959 · wf-form4_167355774353218.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,763

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 3,439 shares sold at prices ranging from $18.04 to $18.08 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 10, 2023 Filed Jan 12, 2023 21:08 UTC
Bonstein SaraChief Financial Officer
SaleCommon Stock 2,857 $18.12 $51,768.84
Disclosure

SEC source: 0001628280-23-000958 · wf-form4_167355767379058.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,031

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 2,857 shares sold at prices ranging from $18.03 to $18.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 10, 2023 Filed Jan 12, 2023 21:06 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 3,194 $17.99 $57,460.06
Disclosure

SEC source: 0001628280-23-000957 · wf-form4_167355760242570.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,487

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing 3,194 shares sold at prices ranging from $17.98 to $18.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:30 UTC
Wise John DraytonChief Commercial Officer
GrantStock Option (right to buy) · Derivative 34,860 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · derivative · entry 3

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,860

Underlying: Common Stock · 34,860 shares

Expires 2033-01-05

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:30 UTC
Wise John DraytonChief Commercial Officer
GrantCommon Stock 7,598 Not disclosed Not disclosed
Disclosure

SEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · nonDerivative · entry 2

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,051

F2 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:30 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 1,160 $19.74 $22,898.40
Disclosure

SEC source: 0001930805-23-000001 · wf-form4_167304064330467.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,453

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:29 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
GrantStock Option (right to buy) · Derivative 29,050 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · derivative · entry 3

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,050

Underlying: Common Stock · 29,050 shares

Expires 2033-01-05

F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:29 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
GrantCommon Stock 6,332 Not disclosed Not disclosed
Disclosure

SEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · nonDerivative · entry 2

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,168

F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:29 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
SaleCommon Stock 720 $19.72 $14,198.40
Disclosure

SEC source: 0001870278-23-000001 · wf-form4_167304054671097.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,836

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · balance_after: Includes 101 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:27 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantStock Option (right to buy) · Derivative 29,050 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · derivative · entry 3

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,050

Underlying: Common Stock · 29,050 shares

Expires 2033-01-05

F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:27 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
GrantCommon Stock 6,332 Not disclosed Not disclosed
Disclosure

SEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · nonDerivative · entry 2

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,594

F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:27 UTC
Schaeffer Orlov S NicoleChief People Strategy Officer
SaleCommon Stock 1,448 $19.73 $28,569.04
Disclosure

SEC source: 0001401017-23-000001 · wf-form4_167304043493381.xml · nonDerivative · entry 1

Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,262

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · balance_after: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:24 UTC
Lewis WilliamDirector · Chair and CEO
GrantStock Option (right to buy) · Derivative 102,540 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001402051-23-000001 · wf-form4_167304024350073.xml · derivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,540

Underlying: Common Stock · 102,540 shares

Expires 2033-01-05

F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:24 UTC
Lewis WilliamDirector · Chair and CEO
GrantCommon Stock 22,353 Not disclosed Not disclosed
Disclosure

SEC source: 0001402051-23-000001 · wf-form4_167304024350073.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,061

F3 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of grant.

F4 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:24 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 7,008 $19.80 $138,758.40
Disclosure

SEC source: 0001402051-23-000001 · wf-form4_167304024350073.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 249,708

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

F2 · price: This is a weighted average sales price representing 7,008 shares sold at prices ranging from $19.78 to $19.805 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:22 UTC
Flammer Martina M.D.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 34,860 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001796960-23-000001 · wf-form4_167304014062436.xml · derivative · entry 4

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,860

Underlying: Common Stock · 34,860 shares

Expires 2033-01-05

F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of the grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:22 UTC
Flammer Martina M.D.Chief Medical Officer
GrantCommon Stock 3,546 Not disclosed Not disclosed
Disclosure

SEC source: 0001796960-23-000001 · wf-form4_167304014062436.xml · nonDerivative · entry 3

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,202

F4 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: one third on each anniversary of the date of grant through the third anniversary date of the date of the grant.

F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:22 UTC
Flammer Martina M.D.Chief Medical Officer
GrantCommon Stock 7,598 Not disclosed Not disclosed
Disclosure

SEC source: 0001796960-23-000001 · wf-form4_167304014062436.xml · nonDerivative · entry 2

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,656

F2 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:22 UTC
Flammer Martina M.D.Chief Medical Officer
SaleCommon Stock 1,374 $19.73 $27,109.02
Disclosure

SEC source: 0001796960-23-000001 · wf-form4_167304014062436.xml · nonDerivative · entry 1

Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,058

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:17 UTC
Bonstein SaraChief Financial Officer
GrantStock Option (right to buy) · Derivative 37,760 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001628280-23-000632 · wf-form4_167303980436597.xml · derivative · entry 3

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,760

Underlying: Common Stock · 37,760 shares

Expires 2033-01-05

F5 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of the grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:17 UTC
Bonstein SaraChief Financial Officer
GrantCommon Stock 5,065 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-000632 · wf-form4_167303980436597.xml · nonDerivative · entry 2

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,888

F4 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: one third on each anniversary of the date of grant through the third anniversary date of the date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:17 UTC
Bonstein SaraChief Financial Officer
GrantCommon Stock 8,232 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-23-000632 · wf-form4_167303980436597.xml · nonDerivative · entry 1

Bonstein Sara · CIK 0001604019 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,823

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

F3 · balance_after: Includes 908 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:08 UTC
Adsett RogerChief Operating Officer
GrantStock Option (right to buy) · Derivative 34,860 $0.00 Strike: $19.74 $0.00
Disclosure

SEC source: 0001685904-23-000001 · wf-form4_167303931068897.xml · derivative · entry 3

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,860

Underlying: Common Stock · 34,860 shares

Expires 2033-01-05

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of the grant.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:08 UTC
Adsett RogerChief Operating Officer
GrantCommon Stock 7,598 Not disclosed Not disclosed
Disclosure

SEC source: 0001685904-23-000001 · wf-form4_167303931068897.xml · nonDerivative · entry 2

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,681

F2 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

F3 · price: Each Restricted Stock Unit was received as a grant on January 5, 2023, for no consideration.

Read SEC document
January 05, 2023 Filed Jan 6, 2023 21:08 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 3,044 $19.75 $60,119.00
Disclosure

SEC source: 0001685904-23-000001 · wf-form4_167303931068897.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,083

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Read SEC document
November 22, 2022 Filed Nov 22, 2022 22:05 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 7,154 $18.84 $134,781.36
Disclosure

SEC source: 0001930805-22-000002 · wf-form4_166915469420395.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,613

F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

Read SEC document
November 22, 2022 Filed Nov 22, 2022 22:03 UTC
Adsett RogerChief Operating Officer
SaleCommon Stock 11,855 $18.80 $222,874.00
Disclosure

SEC source: 0001685904-22-000001 · wf-form4_166915458164192.xml · nonDerivative · entry 1

Adsett Roger · CIK 0001685904 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,127

F1 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

F2 · price: This is the weighted average sales price representing the shares sold at prices ranging from $18.78 to $18.86 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
November 01, 2022 Filed Nov 2, 2022 20:23 UTC PurchaseCommon Stock 10,000 $17.70 $177,000.00
Disclosure

SEC source: 0001182633-22-000002 · wf-form4_166742056037010.xml · nonDerivative · entry 2

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Baby Gator LLC

Disclosed balance after: 15,900

F2 · price: This is the weighted average purchase price representing the shares purchased at prices ranging from $17.68 to $17.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.

F3 · ownership.nature: The Reporting Person is a managing member of Baby Gator LLC.

Read SEC document
October 31, 2022 Filed Nov 2, 2022 20:20 UTC
LEE LEODirector
PurchaseCommon Stock 45,000 $17.69 $796,050.00
Disclosure

SEC source: 0001740789-22-000002 · wf-form4_166742043602523.xml · nonDerivative · entry 1

LEE LEO · CIK 0001740789 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,265

Read SEC document
October 31, 2022 Filed Nov 2, 2022 20:23 UTC PurchaseCommon Stock 20,000 $17.53 $350,600.00
Disclosure

SEC source: 0001182633-22-000002 · wf-form4_166742056037010.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,021

F1 · price: This is the weighted average purchase price representing the shares purchased at prices ranging from $17.32 to $17.63 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.

Read SEC document
October 31, 2022 Filed Jan 12, 2023 21:16 UTC GiftCommon Stock 1,600 $0.00 $0.00
Disclosure

SEC source: 0001628280-23-000964 · wf-form5_167355815576336.xml · nonDerivative · entry 1

SHAROKY MELVIN MD · CIK 0001182633 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,021

Read SEC document
August 10, 2022 Filed Aug 12, 2022 20:19 UTC
Wise John DraytonChief Commercial Officer
SaleCommon Stock 258 $27.79 $7,169.82
Disclosure

SEC source: 0001930805-22-000001 · wf-form4_166033556150179.xml · nonDerivative · entry 1

Wise John Drayton · CIK 0001930805 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,767

F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

F2 · balance_after: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 186,170 $0.00 Strike: $4.55 $0.00
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · derivative · entry 11

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Disclosed balance after: 0

Underlying: Common Stock · 186,170 shares

Expires 2022-09-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 30,630 $0.00 Strike: $3.40 $0.00
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · derivative · entry 10

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Disclosed balance after: 0

Underlying: Common Stock · 30,630 shares

Expires 2022-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 24,977 $28.43 $710,096.11
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 8

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 0

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F6 · price: This is the weighted average sales price representing 24,977 shares sold at prices ranging from $28.26 to $28.72 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 24,977 $4.55 $113,645.35
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 7

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 24,977

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 161,193 $27.75 $4,473,105.75
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 6

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 0

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F5 · price: This is the weighted average sales price representing 161,193 shares sold at prices ranging from $27.26 to $28.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 161,193 $4.55 $733,428.15
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 5

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 161,193

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 6,200 $28.45 $176,390.00
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 4

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 0

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F4 · price: This is the weighted average sales price representing 6,200 shares sold at prices ranging from $28.26 to $28.73 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 6,200 $3.40 $21,080.00
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 6,200

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 24,430 $27.67 $675,978.10
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 0

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 24,430 shares sold at prices ranging from $27.26 to $28.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:18 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 24,430 $3.40 $83,062.00
Disclosure

SEC source: 0001402051-22-000003 · wf-form4_166016268759482.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · Indirect

Disclosed balance after: 24,430

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · ownership.nature: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A 11/1/2020

Read SEC document
July 12, 2022 Filed Jul 12, 2022 20:06 UTC
Smith Michael AlexanderGeneral Counsel, Senior VP
SaleCommon Stock 941 $23.40 $22,019.40
Disclosure

SEC source: 0001870278-22-000001 · wf-form4_165765636118954.xml · nonDerivative · entry 1

Smith Michael Alexander · CIK 0001870278 · General Counsel, Senior VP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,455

F1 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.

F2 · balance_after: Includes 813 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 20:04 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionStock Option (right to buy) · Derivative 96,614 $0.00 Strike: $16.16 $0.00
Disclosure

SEC source: 0001402051-22-000002 · wf-form4_165731066077799.xml · derivative · entry 3

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 96,614 shares

Expires 2026-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 20:04 UTC
Lewis WilliamDirector · Chair and CEO
SaleCommon Stock 96,614 $23.00 $2,222,122.00
Disclosure

SEC source: 0001402051-22-000002 · wf-form4_165731066077799.xml · nonDerivative · entry 2

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 256,716

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F3 · price: This is the weighted average sales price representing 96,614 shares sold at prices ranging from $23.00 to $23.03 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
July 07, 2022 Filed Jul 8, 2022 20:04 UTC
Lewis WilliamDirector · Chair and CEO
Exercise / conversionCommon Stock 96,614 $16.16 $1,561,282.24
Disclosure

SEC source: 0001402051-22-000002 · wf-form4_165731066077799.xml · nonDerivative · entry 1

Lewis William · CIK 0001402051 · Director · Chair and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.